Table 2.
T1 | T2 | T3 | Baseline to postintervention | Baseline to follow-up | |||||
---|---|---|---|---|---|---|---|---|---|
Variable | (N = 46) | (N = 38) | (N = 36) | Δ a | 95% CI | Cohen’s d | Δ a | 95% CI | Cohen’s d |
Psychosocial distress | |||||||||
Perceived stress | 12.2 ± 6.7 | 10.0 ± 6.3 | 11.4 ± 7.2 | −1.5 | −2.8, −0.3 | .39 | −0.8 | −2.5, 1.0 | .14 |
Depressive symptoms | 10.8 ± 8.8 | 7.7 ± 7.9 | 9.9 ± 10.8 | −2.2 | −3.5, −1.1 | .58 | −0.8 | −3.6, 1.9 | .10 |
Anxiety | 7.7 ± 7.8 | 6.3 ± 6.6 | 7.5 ± 7.8 | 0.2 | −1.5, 2.0 | .04 | 1.4 | −0.7, 3.5 | .21 |
Positive affect | 32.9 ± 9.0 | 33.6 ± 9.8 | 34.1 ± 8.8 | 0.6 | −1.2, 2.3 | .11 | 0.5 | −1.1, 2.1 | .10 |
Negative affect | 16.7 ± 6.2 | 14.1 ± 5.4 | 15.9 ± 6.1 | −1.4 | −2.4, −0.3 | .40 | −0.2 | −1.6, 1.2 | .04 |
Health-related quality of life | |||||||||
Physical functioning | 84.4 ± 16.7 | 87.6 ± 13.1 | 83.7 ± 17.0 | 3.5 | −0.7, 8.1 | .26 | 0.0 | −3.9, 3.6 | .00 |
Role limitations—physical | 83.7 ± 30.4 | 87.2 ± 29.8 | 85.4 ± 30.1 | 2.8 | −8.3, 13.2 | .08 | 2.1 | −7.1, 11.4 | .07 |
Role limitations—emotional | 69.6 ± 35.7 | 77.5 ± 37.7 | 75.5 ± 39.7 | 7.4 | −4.6, 19.4 | .20 | 6.2 | −7.1, 20.0 | .15 |
Energy/fatigue | 52.3 ± 19.8 | 58.0 ± 19.4 | 54.6 ± 20.5 | 3.9 | 0.3, 7.6 | .33 | 1.8 | −3.1, 6.6 | .12 |
Emotional well-being | 73.7 ± 15.0 | 80.4 ± 13.1 | 77.2 ± 19.0 | 5.7 | 2.6, 8.8 | .59 | 2.9 | −1.1, 7.0 | .23 |
Social functioning | 79.6 ± 23.6 | 86.8 ± 18.4 | 83.7 ± 22.7 | 5.9 | 1.7, 10.1 | .45 | 3.9 | −1.8, 9.6 | .23 |
Pain | 80.5 ± 17.6 | 77.4 ± 19.9 | 77.3 ± 21.9 | −2.4 | −7.5, 2.6 | .15 | −3.6 | −8.1, 0.9 | .27 |
General health | 66.5 ± 17.8 | 68.9 ± 18.9 | 67.2 ± 18.1 | 0.1 | −4.6, 5.0 | .01 | 0.0 | −4.3, 4.1 | .00 |
CI confidence interval.
aSample size for mean differences (Δ) varies by time point and is calculated using participants with complete data at T1 and T2 or T1 and T3 only.